id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-301730-flv5lnv8	Pandey, Anamika	Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak	2020-10-15		.txt	text/plain	7101	346	50	Despite the previous positive reports of plant-based medications, no successful clinical trials of phyto-anti-COVID drugs could be conducted to date. Medicinal plant extracts have been reported to impede the replication of several viruses including human immunodeficiency virus (HIV), hepatitis B virus (HBV), poxvirus, severe acute respiratory syndrome (SARS) virus, and herpes simplex virus type 2 (HSV-2) (Vermani and Garg, 2002; Kotwal et al., 2005; Huang et al., 2006) . Different researchers are investigating diverse plant forms based on ethnopharmacological data to find effective anti-CoV drugs with novel action mechanisms especially targeting viral replication. Moreover, creating an effective phyto-anti-COVID drug during this pandemic may provide an idea on the duration and the strategy required for the development of potent plant-based therapeutics in case of such random viral outbreaks (Figure 1) .	./cache/cord-301730-flv5lnv8.txt	./txt/cord-301730-flv5lnv8.txt